Gender differences in advanced heart failure: insights from the BEST study
Jalal K. Ghali, MD*,*,
Heidi J. Krause-Steinrauf, MS ,
Kirkwood F. Adams, Jr, MD ,
Steven S. Khan, MD ,
Yves D. Rosenberg, MD ,
Clyde W. Yancy, Jr, MD||,
James B. Young, MD¶,
Steven Goldman, MD#,
Mary Ann Peberdy, MD** and
JoAnn Lindenfeld, MD
* Cardiac Centers of Louisiana, Shreveport, Louisiana, USA
National Heart, Lung, and Blood Institute, Bethesda, Maryland, USA
University of North Carolina, Chapel Hill, North Carolina, USA
Cedars-Sinai Medical Center, Los Angeles, California, USA
|| University of Texas Southwestern, Dallas, Texas, USA
¶ Cleveland Clinic Foundation, Cleveland, Ohio, USA
# Tucson Veteran Affairs Medical Center, Tucson, Arizona, USA
** Virginia Commonwealth University, Medical College of Virginia, Richmond, Virginia, USA
 University of Colorado Health Science Center, Denver, Colorado, USA

View larger version (15K):
[in a new window]
|
Figure 1 Hazard ratios for mortality comparing genders for prespecified patient subgroups adjusted for treatment group. CAD = coronary artery disease; LVEF = left ventricular ejection fraction; NYHA = New York Heart Association.
|
|

View larger version (21K):
[in a new window]
|
Figure 2 Survival curves by gender within ischemia status. CAD = coronary artery disease.
|
|
|